David Brenna

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) are down 13.6 percent in pre-market trading after the company dropped a bombshell that CEO David Hallal and board member Vikas Sinha are leaving the company amid an ongoing audit and finance committee investigation. The news of the departures seems to...